Earnings calls / BAJAJCON

Bajaj Consumer Care Limited Q1 FY27 Earnings Call Summary

Bajaj Consumer Care delivered a robust Q1 FY27 with revenue of ₹341 crores (up over 28% YoY), consolidated EBITDA of ₹84.4 crores (doubled YoY, 24.7% margin)...

Revenue
Margin
Demand
Guidance
Tone

Event Participants

Executives

3
Aakash Gupta, Dilip Kumar Maloo, Naveen Pandey

Analysts

7
Abhijeet Kundu, Divyansh Jaju, Mayur Patel, Mihir Shah, Nishita Shanklesha, Percy Panthaki, Tejas Shah

Financials & KPIs

Metric Reported Commentary
Revenue ₹341 crores Up over 28% YoY; broad-based across channels with selective price increases and MLH reduction aiding realisation
ADHO Volume Growth Low teens (MLH adjusted) Improved from mid-single-digit in prior quarters; led by small packs and sachets across all pack groups and channels
ASP (Consolidated) +29% YoY Reflecting calibrated price increases and portfolio mix
Gross Margin 61.8% Down 120 bps sequentially from 63% (Q4 FY26), but up 510 bps YoY; pressured by West Asia war-related raw material inflation
Advertising Spend 14.6% of revenue Within historical 15–16% range; brand investment maintained with growing shift toward digital/influencer-led campaigns
EBITDA (Consolidated) ₹84.4 crores Doubled YoY; 24.7% margin aided by ~600 bps savings on employee and other fixed costs vs Q1 FY26
PAT ₹70.7 crores 20.7% margin
Growth Portfolio Share ~15–20% of sales Grew high single-digit sequentially despite coconut portfolio value deflation; ADHO ~80% of sales

Geographic & Segment Commentary

  • India – General Trade & Organized Trade: Both channels grew in "strong 20s" with growth across urban retail, wholesale and rural; rural grew in line with urban, sustaining the H2 FY26 recovery. Modern trade and e-commerce performed well across sub-channels and customers, while institutional business remained weak (less than 1% of mix).

  • International Business: Strong rebound after a challenging FY26, with performance across countries giving confidence in sustainable growth. Nepal and Bangladesh delivered continued double-digit growth with margin improvement; MENA, challenged last year, posted very strong growth; Rest of World rebounded strongly after tariff-related disruptions.

  • ADHO – Almond Drop Hair Oil (~80% of sales): Low-teens volume growth on MLH-adjusted basis across all pack groups and channels; small packs and sachets were standout contributors. Consumer metrics continued to trend positive; SOV-SOM ratio robust in traditional media with increasing shift to digital channels.

  • Growth Portfolio – non-ADHO brands (~15–20% of sales): High single-digit sequential growth despite value deflation in the coconut portfolio (largest contributor); volume growth driven by distribution and wider availability, not free volume or grammage increases. Banjara's contributes ~5% of sales with revamp pilots underway; long-term aspiration to grow in high 20s and add meaningfully to overall mix.

Company-Specific & Strategic Commentary

  • Project Aarohan: Distribution expansion initiative executed for the first time in four big states; delivers a 200–300 bps one-time growth delta and is designed as a continuous, multi-year exercise to expand direct distribution and enable wider portfolio execution.

  • Pricing & Margin Management: Selective, calibrated price increases and MLH (per-ml realisation) reductions taken across the portfolio to protect margins against West Asia war-driven raw material inflation; management confirmed no further pricing actions are planned for margin expansion.

  • Brand Investment & Digital Shift: Advertising maintained at 14.6% of revenue (historical 15–16% range); significant investment in influencer-led marketing campaigns across major digital platforms with positive consumer feedback; advertising explicitly not an area for cost squeeze.

  • Growth Portfolio Roadmap: ₹500 crore aspiration progressing; management commits to annual performance disclosure. Coconut rationalisation narrowed the discount to the market leader to sustainable, profitable levels; Banjara's positioned to be the second biggest leg, if not the biggest, of the growth portfolio.

  • M&A: Nothing to disclose on acquisition targets for diversification; market will be updated as and when there is news.

Guidance & Outlook

Metric Guidance / Outlook Commentary
Revenue Growth Double-digit to low teens (medium-to-long-term aspiration) Exponential current growth expected to normalize as base compresses; management would be "disappointed" if double-digit growth is not delivered in any quarter
Gross Margin Q2 FY27 under more stress, easing in Q3/Q4 High-cost inventory in system; spot prices expected to cool sequentially; war situation remains dynamic
EBITDA Margin Low-to-mid 20s (aspiration) No further pricing actions planned; operating leverage and top-line performance will drive flow-through
Advertising Spend ~15–16% of revenue Continued investment; ad spend not being squeezed
Growth Portfolio High 20s growth (long-term) To add meaningfully to overall mix; no short-term guidance; annual disclosure planned

Risks & Constraints

Risk Context
Raw Material Inflation West Asia war drove extreme volatility in petroleum derivatives (LLP) and packaging material; edible oils (mustard, almond) remained at historical highs even in harvest season; high-cost inventory in system will pressure Q2 gross margins
Execution Risk Management identifies consistent market share gains, consumer acquisition, and distribution expansion as the single largest risk to sustaining elevated growth momentum
Geopolitical Uncertainty War situation remains dynamic — appeared resolved weeks ago, now uncertain; directly impacts input cost visibility and margin management
Copra Price Volatility Copra operating in ₹130–140 range over the last couple of months, not following the typical seasonal cycle; unpredictability affects coconut portfolio economics and potential unorganized competition
Competitive Intensity Growth portfolio sub-segments face extremely large competitors; coconut category highly competitive, limiting disclosure frequency
Institutional Business Weakness Institutional channel weak in Q1 FY27; less than 1% of mix, limiting overall impact

Q&A Highlights

Margin Sustainability & One-offs

  • Question: Any one-offs driving the 24.5% EBITDA margin despite muted other-expense growth? Should we expect moderation from here? (Percy Panthaki, IIFL Capital)
  • Answer: No significant one-offs — only natural quarter-to-quarter skew in expense phasing (Naveen Pandey). Q2 gross margin will remain in a tough zone, easing in Q3/Q4; no further pricing actions planned; operating leverage will drive flow-through.

EBITDA Margin Band

  • Question: Does the earlier 20%+ margin stance remain? (Abhijeet Kundu, Antique Stock Broking)
  • Answer: Management is happy to operate in the low-to-mid 20s EBITDA margin band (Naveen Pandey). No quarterly or yearly guidance given; clarified that no expenditure is being postponed — only natural skew between quarters.

Q2 Gross Margin / Inventory

  • Question: Will Q2 inventory be at higher blocked rates, as some consumer staple companies have flagged? (Abhijeet Kundu)
  • Answer: True for certain key commodities, not generic across items; depends on inventory cover and speed of price cooling (Naveen Pandey). Q2 is a quarter where margins cannot be taken for granted; situation remains very dynamic.

ADHO Volume Growth Drivers

  • Question: What drove ADHO volume growth from mid-single-digit to low teens? (Percy Panthaki)
  • Answer: Very good traction across smaller unit price points — small packs and sachets — is aiding momentum (Naveen Pandey).

Growth Portfolio & Banjara's Strategy

  • Question: Why was non-ADHO subdued? Are priorities limited to coconut or is diversification more immediate? (Percy Panthaki)
  • Answer: Coconut grew sequentially despite per-ml value correction — management is happy with progress (Naveen Pandey). Banjara's revamp is underway with pilots; it forms an unambiguous part of the growth portfolio strategy and will likely be the second biggest leg; annual disclosure planned.

Project Aarohan Impact

  • Question: Should we expect more Aarohan benefits? Is there a measurable delta between Aarohan and non-Aarohan states? (Mayur Patel, 360 One AMC; Tejas Shah, Avendus Spark)
  • Answer: First-time execution in four big states; 200–300 bps one-time delta on a small mix (Naveen Pandey). Multi-year benefit as new outlets are added; difficult to segregate contribution.

Growth Normalization & Aspirations

  • Question: Is 28% growth a one-off? Are low-teens aspirations conservative? How should we think about growth against a rising base? (Nishita Shanklesha, Sapphire Capital; Mihir Shah, Nomura)
  • Answer: Exponential growth from price corrections and unrolled actions will settle as bases compress (Naveen Pandey). Medium-to-long-term aspiration is consistent double-digit to low-teens growth; not a quarterly guidance.

Coconut Portfolio & Copra

  • Question: Is coconut volume growth from grammage/MLH changes? How is the market shifting with copra correction? (Mihir Shah, Nomura)
  • Answer: No substantial free volume being given — growth is driven by distribution and wider availability (Naveen Pandey). Copra at ₹130–140, not following typical cycle; unorganized copra markets (e.g., Kerala) are not structurally significant for us; core portfolio is premium to copra, limiting interplay.

Ad Spend Strategy

  • Question: What is the advertisement and promotions strategy for FY27? (Divyansh Jaju, Trinetra Asset Managers)
  • Answer: Historical average is 15–16% of revenue; will operate in that zone (Naveen Pandey). Advertising is not an area of cost squeeze — will continue doubling down and investing consistently over the medium term.

M&A Update

  • Question: Any progress on M&A for diversification this year? (Mayur Patel, 360 One AMC; Nishita Shanklesha, Sapphire Capital)
  • Answer: Nothing to disclose; the market will be updated as and when there is news (Naveen Pandey).

Single Biggest Risk

  • Question: What is the single biggest risk to sustaining ~20% growth over the next two years? (Tejas Shah, Avendus Spark)
  • Answer: Execution risk — consistently gaining market share, acquiring consumers, and expanding distribution to more outlets; all other factors are secondary (Naveen Pandey).

Key Takeaway

Bajaj Consumer Care delivered a robust Q1 FY27 with revenue of ₹341 crores (up over 28% YoY), consolidated EBITDA of ₹84.4 crores (doubled YoY, 24.7% margin) and PAT of ₹70.7 crores (20.7% margin), despite West Asia war-driven raw material inflation that compressed gross margin 120 bps sequentially to 61.8% (still up 510 bps YoY). Growth was broad-based — both general and organized trade grew in strong 20s, rural matched urban, and international business rebounded across Nepal, Bangladesh, MENA and Rest of World. ADHO delivered low-teens volume growth led by sachets and small packs, while the growth portfolio (~15–20% of sales) grew high single-digit sequentially. Management expects gross margin stress to peak in Q2 FY27 before easing in H2, targets low-to-mid 20s EBITDA margins and consistent double-digit to low-teens revenue growth over the medium term. Key strategic drivers include Project Aarohan distribution expansion (200–300 bps one-time delta) and the ₹500 crore growth portfolio roadmap. Watch Q2 margin trajectory, copra price volatility, and execution on market share gains as the base normalizes.

What you get with InvestorStack

Institutional-grade research, built for individual investors.

  • Research Reports for 1,800+ companies
  • Detailed valuation models
  • Growth triggers, Risks, KPIs, Read between the lines
  • Scans, One pagers, Industry research reports
Try for free